Literature DB >> 19844720

Lung involvement in patients with primary Sjögren's syndrome: what are the predictors?

Veli Yazisiz1, Gokhan Arslan, Irem Hicran Ozbudak, Sema Turker, Funda Erbasan, Ali Berkant Avci, Omer Ozbudak, Ender Terzioglu.   

Abstract

The aim of this study was to investigate the prevalence, predictors and radiological findings of primary Sjögren's syndrome (pSS)-associated lung involvement. This retrospective cohort study included 123 patients with demographic, clinical, laboratory and radiological data who were diagnosed with pSS. Lung involvement was defined based on the presence of pulmonary signs/symptoms and/or impaired pulmonary function tests along with alterations in high-resolution computerized tomography (HRCT). Thirty patients (24.4%) had pulmonary signs/symptoms at the initial presentation and/or during the follow-up period. Based on the criteria, 14 patients (11.4%) were defined as having pSS with lung involvement. The smoking rate, male/female ratio and the mean ages were found to be higher in patients with lung involvement (P < 0.05). Positive IgM-rheumatoid factor (RF), anti-La and anti-Ro results, the presence of hypergammaglobulinemia and lymphopenia had high specificity despite the low sensitivity rates to detect pSS-associated lung disease. A significant difference was found in forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV(1)) results between the patients with and without lung involvement. Impaired FEV(1) had high specificity and positive predictive value compared to impaired FVC, particularly in non-smoker patients. The most frequent HRCT finding was ground-glass attenuation (64.3%). Other common findings were bronchiectasis, reticular pattern and honeycombing. The lesions involved predominantly the lower lobes. In conclusion, the presence of hypergammaglobulinemia and lymphopenia, positivity for RF, anti-La and anti-Ro, and impaired (FVC) and/or FEV(1) values could be the predictive parameters with a high specificity despite the low sensitivity rates. Smoking history, male gender and age are also risk factors. These parameters may be helpful to distinguish pSS-associated lung involvement from lung disorders unrelated to pSS.

Entities:  

Mesh:

Year:  2009        PMID: 19844720     DOI: 10.1007/s00296-009-1152-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Primary Sjögren's syndrome and associated lung disease: CT findings in 50 patients.

Authors:  T Franquet; A Giménez; J M Monill; C Díaz; C Geli
Journal:  AJR Am J Roentgenol       Date:  1997-09       Impact factor: 3.959

3.  Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.

Authors:  E L Alexander; F C Arnett; T T Provost; M B Stevens
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

4.  Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients.

Authors:  Mario García-Carrasco; Antoni Sisó; Manuel Ramos-Casals; José Rosas; Gloria de la Red; Victor Gil; Susana Lasterra; Ricard Cervera; Josep Font; Miguel Ingelmo
Journal:  J Rheumatol       Date:  2002-04       Impact factor: 4.666

Review 5.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

6.  Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment.

Authors:  D Deheinzelin; V L Capelozzi; R A Kairalla; J V Barbas Filho; P H Saldiva; C R de Carvalho
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

7.  Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study.

Authors:  Elke Theander; Rolf Manthorpe; Lennart T H Jacobsson
Journal:  Arthritis Rheum       Date:  2004-04

8.  Diagnostic performance of minor salivary gland biopsy, serological and clinical data in Sjögren's syndrome: a retrospective analysis.

Authors:  Veli Yazisiz; Ali Berkant Avci; Funda Erbasan; Evren Kiriş; Ender Terzioğlu
Journal:  Rheumatol Int       Date:  2008-09-18       Impact factor: 2.631

9.  Is the heart affected in primary Sjögren's syndrome? An echocardiographic study.

Authors:  V A Vassiliou; I Moyssakis; K A Boki; H M Moutsopoulos
Journal:  Clin Exp Rheumatol       Date:  2008 Jan-Feb       Impact factor: 4.473

Review 10.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  H C Cain; P W Noble; R A Matthay
Journal:  Clin Chest Med       Date:  1998-12       Impact factor: 2.878

View more
  31 in total

1.  Rapid progressive interstitial lung disease as initial manifestation of primary Sjögren's syndrome: a case report.

Authors:  Yihua Lin; Qun Yi; Deyun Cheng
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

3.  Survival analysis of patients with Sjögren's syndrome in Turkey: a tertiary hospital-based study.

Authors:  Veli Yazisiz; Mesut Göçer; Funda Erbasan; İsmail Uçar; Bengisu Aslan; Şuayp Oygen; Edip Gökalp Gök; Mustafa Ender Terzioğlu
Journal:  Clin Rheumatol       Date:  2019-09-25       Impact factor: 2.980

4.  Sjogren's Syndrome and Pulmonary Disease.

Authors:  Ruben A Peredo; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  The Complex Role of the Lung in the Pathogenesis and Clinical Outcomes of Rheumatoid Arthritis.

Authors:  Lindsay B Kelmenson; M Kristen Demoruelle; Kevin D Deane
Journal:  Curr Rheumatol Rep       Date:  2016-11       Impact factor: 4.592

Review 6.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  George Stojan; Alan N Baer; Sonye K Danoff
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

7.  Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement.

Authors:  Andreina Manfredi; Marco Sebastiani; Stefania Cerri; Giulia Cassone; Pietrantonio Bellini; Giovanni Della Casa; Fabrizio Luppi; Clodoveo Ferri
Journal:  Clin Rheumatol       Date:  2017-03-21       Impact factor: 2.980

Review 8.  Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.

Authors:  Rekha Vij; Mary E Strek
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

9.  A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.

Authors:  Xin Dong; Junfei Zhou; Xiaojuan Guo; Yifan Li; Yuetong Xu; Qiang Fu; Yong Lu; Yi Zheng
Journal:  Clin Rheumatol       Date:  2018-09-22       Impact factor: 2.980

10.  Effect of cigarette smoking and alcohol consumption on disease activity and physical functioning in ankylosing spondylitis: a cross-sectional study.

Authors:  Shengli Zhang; Yan Li; Xiangjin Xu; Xiugao Feng; Dawei Yang; Guiying Lin
Journal:  Int J Clin Exp Med       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.